Chateauguay, Canada

Benoit Thomas Dore


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Benoit Thomas Dore

Introduction

Benoit Thomas Dore is a notable inventor based in Chateauguay, Canada. He has made significant contributions to the field of medical treatments, particularly in the area of oncology. With a total of three patents to his name, Dore's work focuses on innovative methods for inhibiting cell proliferation in solid tumors.

Latest Patents

Dore's latest patents include methods of treatment that utilize a Vitamin D3 analog to induce inhibition or loss of cell proliferation in solid tumors. Additionally, he has developed methods that employ trans retinoic acid in conjunction with a Vitamin D3 analog for similar therapeutic effects. Another aspect of his work involves the use of a Vitamin D3 metabolite, along with trans retinoic acid, to achieve the same goal of inhibiting cell proliferation in solid tumors.

Career Highlights

Benoit Thomas Dore is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His innovative approaches to cancer treatment have positioned him as a key figure in the research and development of effective therapies.

Collaborations

Dore has collaborated with esteemed colleagues such as Richard Lewis Momparler and Milan R Uskokovic. These partnerships have further enhanced the impact of his research and innovations in the medical field.

Conclusion

Benoit Thomas Dore's contributions to cancer treatment through his patented methods highlight his dedication to advancing medical science. His work continues to inspire and pave the way for future innovations in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…